Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9807763 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL6257271 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL4366918 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL3237794 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL9807794 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL10071610 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL4755851 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL9567939 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL7167469 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| Hydrochloric Acid SCHEMBL5267014 | 0.98 | DNM1 (0.46) | TSHRDNM1ALDH1A1KCNH2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100233575-A1 | QUATERNARY AMMONIUM COMPOUNDS AND THEIR USES | IONIC POLYMER SOLUTIONS LIMITED (GB) | 2010-09-16 | — | — | US | disclosed |
| US-20090202836-A1 | METHODS OF FORMING A BARRIER | NOVEL POLYMER SOLUTIONS LTD. | 2009-08-13 | — | — | US | disclosed |
| US-20080199755-A1 | CONDUCTIVE POLYMERS | IONIC POLYMER SOLUTIONS LIMITED (GB) | 2008-08-21 | — | — | US | disclosed |
| US-4543411-A | RUTHENIUM CONTAINING CATALYST MIXED WITH PHOSPHONIUM SALT | TEXACO INC. (US) | 1985-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233575-A1 | QUATERNARY AMMONIUM COMPOUNDS AND THEIR USES | KCNJ1, KCNJ11, AQP4 | TSHR 3971/4885DNM1 211/4885ALDH1A1 3502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.